Crossref journal-article
Elsevier BV
Virology (78)
Bibliography

Aiken, C. (1998). Mechanistic Independence of Nef and Cyclophilin A Enhancement of Human Immunodeficiency Virus Type 1 Infectivity. Virology, 248(1), 139–147.

Authors 1
  1. Christopher Aiken (first)
References 37 Referenced 19
  1. 10.1128/JVI.70.6.3536-3544.1996 / J. Virol. / Spontaneous mutations in the human immunodeficiency virus type 1gag by Aberham (1996)
  2. 10.1128/JVI.72.1.303-308.1998 / J. Virol. / Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A by Ackerson (1998)
  3. 10.1128/JVI.59.2.284-291.1986 / J. Virol. / Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone by Adachi (1986)
  4. 10.1128/JVI.71.8.5871-5877.1997 / J. Virol. / Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A by Aiken (1997)
  5. 10.1016/0092-8674(94)90360-3 / Cell / Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain by Aiken (1994)
  6. 10.1128/JVI.69.8.5048-5056.1995 / J. Virol. / Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis by Aiken (1995)
  7. 10.1128/JVI.69.4.2451-2461.1995 / J. Virol. / Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with HIV protein-cyclophilin A interactions by Billich (1995)
  8. 10.1128/JVI.70.8.5170-5176.1996 / J. Virol. / Cyclosporin A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A by Braaten (1996)
  9. 10.1128/JVI.70.6.3551-3560.1996 / J. Virol. / Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription by Braaten (1996)
  10. 10.1128/JVI.66.5.2814-2820.1992 / J. Virol. / A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication by Charneau (1992)
  11. 10.1128/MCB.7.8.2745 / Mol. Cell Biol. / High-efficiency tranformation of mammalian cells by plasmid DNA by Chen (1987)
  12. 10.1006/viro.1995.1502 / Virology / The growth advantage conferred by HIV-1nef by Chowers (1995)
  13. 10.1128/JVI.68.5.2906-2914.1994 / J. Virol. / Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intactnef by Chowers (1994)
  14. 10.1016/0042-6822(92)90772-H / Virology / Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes by de Ronde (1992)
  15. 10.1128/JVI.70.9.5751-5757.1996 / J. Virol. / The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811 by Dorfman (1996)
  16. 10.1038/372359a0 / Nature / Specific incorporation of cyclophilin A into HIV-1 virions by Franke (1994)
  17. 10.1016/0092-8674(95)90097-7 / Cell / HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase by Gallay (1995)
  18. 10.1016/S0092-8674(00)81823-1 / Cell / Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid by Gamble (1996)
  19. 10.1128/JVI.69.7.4112-4121.1995 / J. Virol. / Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef by Goldsmith (1995)
  20. 10.1073/pnas.89.17.8351 / Proc. Natl. Acad. Sci. USA / Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506 by Karpas (1992)
  21. 10.1128/JVI.63.9.3708-3713.1989 / J. Virol. / Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression by Kim (1989)
  22. 10.1128/JVI.66.4.2232-2239.1992 / J. Virol. / Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene by Kimpton (1992)
  23. 10.1016/S0092-8674(00)81276-3 / Cell / Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain by Lee (1996)
  24. 10.1016/0092-8674(93)90637-6 / Cell / Human Immunodeficiency Virus type 1 Gag protein binds to cyclophilins A and B by Luban (1993)
  25. 10.1084/jem.179.1.101 / J. Exp. Med. / The human immunodeficiency virus-1nef by Miller (1994)
  26. {'key': '10.1006/viro.1998.9254_VY989254RF26', 'first-page': '570', 'article-title': 'Expression of the human immunodeficiency virus type (HIV-1)nef', 'volume': '69', 'author': 'Miller', 'year': '1995', 'journal-title': 'J. Virol.'} / J. Virol. / Expression of the human immunodeficiency virus type (HIV-1)nef by Miller (1995)
  27. 10.1128/JVI.70.7.4283-4290.1996 / J. Virol. / Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein by Pandori (1996)
  28. 10.1128/AAC.38.8.1763 / Antimicrob. Agents Chemother. / Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog by Rosenwirth (1994)
  29. 10.1002/j.1460-2075.1995.tb07024.x / EMBO J. / Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not down-regulation of CD4 by Saksela (1995)
  30. 10.1073/pnas.91.4.1539 / Proc. Natl. Acad. Sci. USA / Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes by Sawai (1994)
  31. 10.1128/JVI.69.7.4053-4059.1995 / J. Virol. / Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell by Schwartz (1995)
  32. 10.1128/JVI.67.8.4639-4650.1993 / J. Virol. / Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo by Shugars (1993)
  33. 10.1084/jem.179.1.115 / J. Exp. Med. / The importance ofnef by Spina (1994)
  34. 10.1128/JVI.69.2.814-824.1995 / J. Virol. / Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication by Steinkasserer (1995)
  35. 10.1038/372363a0 / Nature / Functional association of cyclophilin A with HIV-1 virions by Thali (1994)
  36. 10.1006/viro.1996.0240 / Virology / Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase by Welker (1996)
  37. 10.1006/viro.1993.1230 / Virology / Effect ofnef by Zazopoulos (1993)
Dates
Type When
Created 22 years, 10 months ago (Oct. 7, 2002, 2:48 p.m.)
Deposited 4 years, 3 months ago (May 3, 2021, 4:59 a.m.)
Indexed 1 year, 4 months ago (April 5, 2024, 12:17 p.m.)
Issued 27 years ago (Aug. 1, 1998)
Published 27 years ago (Aug. 1, 1998)
Published Print 27 years ago (Aug. 1, 1998)
Funders 0

None

@article{Aiken_1998, title={Mechanistic Independence of Nef and Cyclophilin A Enhancement of Human Immunodeficiency Virus Type 1 Infectivity}, volume={248}, ISSN={0042-6822}, url={http://dx.doi.org/10.1006/viro.1998.9254}, DOI={10.1006/viro.1998.9254}, number={1}, journal={Virology}, publisher={Elsevier BV}, author={Aiken, Christopher}, year={1998}, month=aug, pages={139–147} }